Covishield, Covaxin, ZyCoV-D Makers to Assess Efficacy of Their Vaccine as They Await Data on Omicron

Sources say ‘high chances’ that Covaxin will work against the new Omicron variant while Covishield maker AstraZeneca-SII is in wait-and-watch mode.